CRIS Current Research Information System

SABATTINI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.818
EU - Europa 4.064
AS - Asia 2.516
AF - Africa 296
SA - Sud America 16
OC - Oceania 3
Totale 12.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.792
GB - Regno Unito 1.149
CN - Cina 860
SE - Svezia 687
VN - Vietnam 639
SG - Singapore 621
DE - Germania 564
IT - Italia 501
UA - Ucraina 302
IN - India 248
IE - Irlanda 188
FR - Francia 160
RU - Federazione Russa 160
ZA - Sudafrica 92
TG - Togo 91
EE - Estonia 67
CH - Svizzera 64
CI - Costa d'Avorio 52
FI - Finlandia 52
JO - Giordania 44
BG - Bulgaria 40
NG - Nigeria 36
BE - Belgio 35
IR - Iran 26
CA - Canada 22
LU - Lussemburgo 19
SC - Seychelles 17
HR - Croazia 16
JP - Giappone 15
GR - Grecia 14
ID - Indonesia 14
NL - Olanda 14
BR - Brasile 9
TR - Turchia 9
LB - Libano 8
PH - Filippine 7
RO - Romania 7
HK - Hong Kong 5
PL - Polonia 5
AT - Austria 4
AU - Australia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
ES - Italia 3
KR - Corea 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
BD - Bangladesh 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
PA - Panama 2
SA - Arabia Saudita 2
TW - Taiwan 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
VE - Venezuela 1
Totale 12.713
Salva come PNG Salva come JPEG
Città #
Southend 1.042
Fairfield 764
Singapore 560
Chandler 476
Ashburn 441
Dong Ket 394
Woodbridge 334
Houston 330
Seattle 327
Wilmington 327
Cambridge 284
Ann Arbor 273
Princeton 270
Santa Clara 189
Dublin 188
Jacksonville 179
Boardman 157
Nanjing 118
Westminster 106
Lomé 91
Padova 89
Bologna 79
Bremen 78
Berlin 77
New York 74
Beijing 65
Jinan 57
Bern 56
Abidjan 52
Saint Petersburg 51
Shenyang 46
Amman 44
Hebei 44
Mülheim 44
San Diego 44
Nanchang 42
Helsinki 41
Sofia 40
Abeokuta 35
Brussels 35
Tianjin 33
Changsha 32
Milan 32
Hyderabad 28
Medford 26
Redwood City 26
Zhengzhou 26
Redmond 24
Hangzhou 23
Jiaxing 22
Guangzhou 21
San Venanzo 20
Turin 20
Olalla 19
Taizhou 19
Des Moines 18
Haikou 18
Norwalk 18
Rome 18
Shanghai 17
Dearborn 16
Mahé 16
Los Angeles 15
Dudelange 14
Jakarta 14
Fuzhou 13
London 13
Ningbo 13
Toronto 13
Falls Church 12
Tokyo 12
Florence 11
Lappeenranta 11
Leawood 11
Taiyuan 11
Kunming 10
Lanzhou 10
Fremont 9
Phoenix 9
Verona 9
Bühl 8
Foshan 8
Andover 7
Ardabil 7
Chengdu 7
Moscow 7
Ravenna 7
Shenzhen 7
Zola Predosa 7
Istanbul 6
Pune 6
San Francisco 6
São Paulo 6
Wenzhou 6
Zanjan 6
Chicago 5
Frankfurt am Main 5
Jesi 5
Lausanne 5
Monmouth Junction 5
Totale 8.771
Salva come PNG Salva come JPEG
Nome #
Biology and treatment of follicular lymphoma. 219
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 194
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 187
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 179
Comparison of JAK2V617F-positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology 169
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens 168
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 167
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 160
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis 160
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 157
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 155
A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy. 153
Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience 150
CD30 expression in peripheral T-cell lymphomas 142
Anaplastic Large Cell Lymphoma: a critical reappraisal 141
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 141
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 139
A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain 139
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 138
BCL10 down-regulation in peripheral T-cell lymphomas. 136
CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation. 133
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 133
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 132
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 132
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 132
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 132
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 130
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 130
Histopathology of B-cell chronic lymphocytic leukemia. 129
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 127
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 127
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 126
Pathobiology of hodgkin lymphoma. 126
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 125
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 124
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 123
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. 122
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 121
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 121
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 121
First Italian birth after cryopreserved ovarian tissue transplantation in a patient affected by non-Hodgkin's lymphoma 121
Prognostic markers in peripheral T-cell lymphoma. 119
Pathobiology of anaplastic large cell lymphoma. 118
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 118
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. 116
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 115
Brownish asymptomatic lesions on the arms and legs 114
Simple diagnostic assay for hairy cell leukemia by cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 113
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 112
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. 112
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 112
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis 110
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 109
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 109
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 109
Unusual inflammatory and hyperkeratotic halo naevus in children. 108
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 107
Small bowel obstruction caused by a large B-cell lymphoma in a patient with multicentric Castleman’s disease: an unusual occurrence 106
Pathobiology of ALK-negative anaplastic large cell lymphoma. 105
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 105
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in 5 cases. 104
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 104
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 104
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 104
Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis. 99
Bone marrow in Hodgkin lymphoma and mimickers. 99
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 99
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 98
Pathobiology of acute lymphoblastic leukemia. 98
null 98
Peripheral T-cell lymphoma. 97
Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues. 97
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 96
Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience 96
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 95
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease. 94
Primary cutaneous lymphomas: a reprisal 94
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 93
Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia. 93
Granulomatous tattoo reaction in a nivolumab-treated patient 93
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 92
Lymphoma classification: Past, present and future 90
Marker expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score. 89
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 88
Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays. 87
Detection of LMO2 in Normal Human Tissue and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody. 87
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers. 86
Tissue micro-array in haematopathology:present usage and potential. 85
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. 84
Low-dose methotrexate as treatment of myeloproliferative neoplasms: Proof of principle of clinical activity 84
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 84
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 83
Lymphoplasmacytic lymphoma and marginal zone lymphoma: diagnostic challenges 82
Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. 81
Peripheral T-cell lymphoma. A still uncurable disease? 80
Pathobiology of Peripheral T-cell lymphomas. 79
Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma. Report of 2 cases. 79
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma 78
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. 77
Proliferation centres in chronic lymphocytic leucemia: correlation with cytogenetic and clinicobiological features in 183 patients analyzed on tissue-microarrays. 72
Totale 11.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.605
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.041 0 0 0 0 0 306 384 403 417 208 125 198
2020/20211.909 327 128 49 77 26 88 35 90 187 64 96 742
2021/20222.176 178 93 135 179 239 106 43 151 82 172 468 330
2022/20232.483 295 390 145 311 177 186 72 125 409 65 188 120
2023/2024713 37 120 62 56 64 159 45 52 23 52 13 30
2024/20251.606 136 447 283 209 391 140 0 0 0 0 0 0
Totale 13.054